Supplementary Data from CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules

MLA

Zhong Chen, et al. Supplementary Data from CK2 Modulation of NF-ΚB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In Vitro or In Vivo via Sub–50-Nm Nanocapsules. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c3254a839b3003d27b7b014c50e71b1&authtype=sso&custid=ns315887.

APA

Zhong Chen, Carter Van Waes, Khalil Ahmed, Gretchen Unger, Vicci Korman, Hai Lu, Pattatheyil Arun, Xinping Yang, Reza Ehsanian, Michael Hu, Oumou T. Diallo, & Matthew S. Brown. (2023). Supplementary Data from CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules.

Chicago

Zhong Chen, Carter Van Waes, Khalil Ahmed, Gretchen Unger, Vicci Korman, Hai Lu, Pattatheyil Arun, et al. 2023. “Supplementary Data from CK2 Modulation of NF-ΚB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In Vitro or In Vivo via Sub–50-Nm Nanocapsules,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c3254a839b3003d27b7b014c50e71b1&authtype=sso&custid=ns315887.